T. László

In situ cell cycle analysis in giant cell tumor of bone reveals patients with elevated risk of reduced progression-free survival.

P. Picci, M. Szendrői, Z. Sápi, 2019, Bone.

Revealing a Phenotypical Appearance of Ibrutinib Resistance in Patients With Chronic Lymphocytic Leukaemia by Flow Cytometry

Z. Borbényi, Gábor Szalóki, Á. Czeti, 2022, Pathology & Oncology Research.

Screening and monitoring of the BTKC481S mutation in a real‐world cohort of patients with relapsed/refractory chronic lymphocytic leukaemia during ibrutinib therapy

P. Csermely, L. Gergely, E. Sebestyén, 2021, British journal of haematology.

Landscape of BCL2 Resistance Mutations in a Real-World Cohort of Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax

R. Szász, D. Alpár, Z. Pauker, 2023, International journal of molecular sciences.